HCPLive

Psoriatic Arthritis 
The MD Magazine Psoriatic Arthritis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Sponsored

Researchers Aim to Determine the Two Subtypes of Crohn's Disease
Researchers from the University of North Carolina examined the gene expression and regulation in colon tissue from patients to better understand the cellular and molecular mechanisms that make up Crohn’s disease.
With extensive literature review and expert input, the ACR and the American Association of Hip and Knee Surgeons (AAHKS) have come together to propose a set of guidelines for medication during the perioperative period for patients undergoing knee or hip arthroplasty.
Prescribing rheumatologists discussed drug interactions, costs, contraindications, and severity of side effects with less than 50% of the patients in the study to whom they had prescribed disease-modifying antirheumatic drugs.
Speaking at ACR 2016, the current chair of the Spondyloarthritis Research and Treatment Network (SPARTAN) presented data that showed that a combination of inflammatory drugs may inhibit ankylosis, the painful fusion of bones.
A report out of Cedars-Sinai Medical Center shows a reduction in hip disease progression in ankylosing spondylitis patients who receive anti-tumor necrotics factor treatment.
Philip Mease shared that the and his team are in the midst of preparing the content of the studies for publication to ensure continued education of psoriatic arthritis treatment.
At the ACR/ARHP annual meeting in Washington, DC, Philip Mease, MD, Swedish Medical Center, University of Washington, discussed the highlights from two psoriatic arthritis studies, OPAL Broaden and OPAL Beyond.
Nearly one-third of patients with plaque psoriasis will also be diagnosed with psoriatic arthritis. While somewhat common, this diagnosis requires a different approach to care in order to help patients better manage their symptoms.
For many patients, chronic idiopathic urticaria can be a debilitating condition affecting them at all hours of the day and making living with the condition very difficult. Because of this, the need for newer, more effective treatments is driving the field forward at a rapid pace.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$